Search results for: safe savings tip
May 20, 2020 video: Maine Importation Update
Maine submitted a state importation plan to the U.S. Department of Health and Human Services (HHS) recently to meet its own May 1, 2020 deadline. Given the deep structural flaws in both the idea of importing medicine from Canada and in Maine’s application to do so, PSM wonders if there is a better use of Maine taxpayer dollars than to continue to pursue this idea.
[...]PSM Testimony: NY state bill AB 7954 (Wholesale Canadian drug importation)
PSM submitted a letter to leaders in the New York State legislature opposing a legislative proposal (AB 7954) to setup a wholesale Canadian drug importation program. The bill died right before end of session.
[...]Wyoming’s Dept. of Health Recommends The State Not Attempt A Drug Importation Program
Wyoming is one of many states that decided to examine if importing drugs would provide significant savings to its citizens. In a hearing in August and a report released today, they took a critical look at the issue and the Department of Health recommends that the state not pursue the idea for several key reasons…
[...]An Analysis Of New Mexico’s Draft Canadian Drug Importation Plan
The state of New Mexico released a draft of its Canadian drug importation plan. PSM analyzed the plan, paying particular attention to concerns pharmacists might have about how drug importation might affect their patients and business…
[...]Are below cost reimbursement practices by Pharmacy Benefit Managers creating opportunity for criminals to enter the legitimate supply chain?
PBMs, by under reimbursing pharmacies, are creating a demand for pharmacies to seek lower priced medications even when they can’t exist at that price.. Criminals appear to be happy to become part of the supply chain.
[...]PSM analysis of Texas legislation HB 25, foreign drug importation
H.B. 25 would require Texas’ Health and Human Services Commission to design a program for bulk importing prescription medicines under 21 USC 384 of the U.S. Food, Drug, and Cosmetics Act, more commonly known as a Section 804 State Importation Program (SIP). Below, we outline the many reasons this proposal is unsafe and unworkable.
[...]Maine’s Medicaid program analysis shows the truth: importing medicine from Canada would cost more, not less.
In an analysis of 50 prospective drugs, Maine’s Medicaid program found that it would lose nearly a million additional dollars ($927,983.28, to be exact) importing these drugs from Canada. How can this be? For many reasons, Canada is not the land of cheap drugs people think it is.
[...]January 9, 2023: New Warning Letter Is A Good Reminder To Use Licensed Pharmacies.
The FDA issued a warning to a rogue pharmacy website. The DEA and Discovery released educational resources for school children. News related to counterfeit pills made with fentanyl and other drugs in 16 states.
[...]Colorado’s dilemma: Should we save our citizens $141 million dollars this year or just burn millions to make a political point?
When Colorado published its list of prospective drugs to import in 2020, the states own numbers showed they could have saved more than $43 million just by switching to U.S. generics. Now, that number is $141 million.
[...]Director of Health and Science Policy at Citizens Against Government Waste Calls Drug Importation Dangerous
Instead of wasting time and money on dangerous and faulty importation proposals, Congress should encourage the FDA to speed up the drug approval process and reduce the cost of program and application fees for future drug development. In 2022, the application fee for a human drug application will cost $1.6 million for drugs that don’t require clinical data and $3.1 million for medicines that do need clinical data.
[...]